Medicinal products for the blood, blood-forming organs and the cardiovascular system | Tenderlake

Medicinal products for the blood, blood-forming organs and the cardiovascular system

Contract Value:
EUR 485K - 485K
Notice Type:
Contract Notice
Published Date:
20 March 2020
Closing Date:
24 April 2020
Location(s):
FRH03 Ille-et-Vilaine (FR FRANCE)
Description:
Blood derivatives

The public market is a framework agreement which fixes all the contractual stipulations. It is executed as and when order forms are issued under the conditions set out in articles R. 2162-13 and R. 2162-14 of the public procurement code. The framework agreement is concluded without minimum amount and without maximum amount for its entire period of validity within the meaning of article R. 2162-4, 3º of the public procurement code. The public contract is concluded for a period going from its date of notification to 30.9.2021.

Human albumin 40 mg / ml and 200 mg / ml, solution for infusion, all strengths (quantities expressed in grams)

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Human hepatitis B immunoglobulins, 100 IU / ml in pre-filled syringe

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Multipurpose immunoglobulins of human origin for intravenous administration 50 mg / ml, all strengths (quantities expressed in grams)

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Multipurpose immunoglobulins of human origin for intravenous administration 100 mg / ml, all strengths (quantities expressed in grams)

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Multipurpose immunoglobulins of human origin for subcutaneous administration, concentration 200 mg / ml, all strengths (quantities expressed in grams)

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Multipurpose immunoglobulins of human origin for subcutaneous administration, concentration 165 mg / ml, all strengths (quantities expressed in grams)

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Multipurpose immunoglobulins of human origin for subcutaneous administration, schedule of administration every 3 - 4 weeks (quantities expressed in grams)

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

C1 esterase inhibitor in the treatment of angioneurotic edema attacks

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

C1 esterase inhibitor in the treatment and long-term prophylaxis of angioneurotic edema attacks

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Human anti-tetanus immunoglobulins, 250 IU in pre-filled syringe

All of the supplies that can be ordered are described in the Particular Technical Clauses (CCTP). The estimated quantities of the public contract are indicated in the consultation regulations and are given for the total duration of the contract. These quantities have no contractual value.

Download full details as .pdf
The Buyer:
Centre hospitalier universitaire de Pontchaillou
CPV Code(s):
33620000 - Medicinal products for the blood, blood-forming organs and the cardiovascular system